2 articles, transcripts, and reports
Akebia Therapeutics Inc (AKBA) Q1 2020 earnings call dated May 05, 2020 Corporate Participants: Kristen Sheppard — Vice President, Investor Relations John Butler — President and Chief Executive Officer…
— Akebia Therapeutics (NASDAQ: AKBA) reported fourth quarter 2019 loss of $0.79 per share vs. expected loss of $0.47 per share. — Revenue rose 16%…
